Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Shares Outstanding (Weighted Average) (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $65.4 million as the latest value for Q3 2024.

  • Quarterly Shares Outstanding (Weighted Average) rose 144.45% to $65.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $65.4 million through Sep 2024, up 144.45% year-over-year, with the annual reading at $3.7 million for FY2023, 81.17% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2024 was $65.4 million at SELLAS Life Sciences, up from $40.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $65.4 million in Q3 2024, with the low at $558000.0 in Q3 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $17.7 million, with a median of $15.5 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) plummeted 91.2% in 2021, then soared 3292.93% in 2022.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $1.4 million in 2020, then skyrocketed by 1012.15% to $15.5 million in 2021, then rose by 25.29% to $19.4 million in 2022, then crashed by 81.17% to $3.7 million in 2023, then soared by 1691.73% to $65.4 million in 2024.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $65.4 million, $40.3 million, and $41.8 million for Q3 2024, Q2 2024, and Q1 2024 respectively.